LTR Pharma (ASX:LTP) partnered with pharmaceutical wholesaler Symbion to establish national distribution capabilities for Spontan, a nasal spray treatment for erectile dysfunction, according to a Wednesday filing with the Australian bourse.
Symbion will offer warehousing, inventory management, and nationwide distribution services for Spontan starting in March, the filing said.
The operational integration is scheduled for rollout in the second quarter, per the filing.
Shares were up 12% in midday trade Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.